710 related articles for article (PubMed ID: 10591040)
1. Predicted three-dimensional structural models of venom serine protease inhibitors and their interactions with trypsin and chymotrypsin.
Azim MK; Grossmann JG; Zaidi ZH
J Nat Toxins; 1999 Oct; 8(3):363-84. PubMed ID: 10591040
[TBL] [Abstract][Full Text] [Related]
2. Affinity and specificity of serine endopeptidase-protein inhibitor interactions. Empirical free energy calculations based on X-ray crystallographic structures.
Krystek S; Stouch T; Novotny J
J Mol Biol; 1993 Dec; 234(3):661-79. PubMed ID: 8254666
[TBL] [Abstract][Full Text] [Related]
3. Purification, characterization and primary structure of a chymotrypsin inhibitor from Naja atra venom.
Zhou XD; Jin Y; Lu QM; Li DS; Zhu SW; Wang WY; Xiong YL
Comp Biochem Physiol B Biochem Mol Biol; 2004 Feb; 137(2):219-24. PubMed ID: 14990218
[TBL] [Abstract][Full Text] [Related]
4. S1 subsite in snake venom thrombin-like enzymes: can S1 subsite lipophilicity be used to sort binding affinities of trypsin-like enzymes to small-molecule inhibitors?
Silva FP; De-Simone SG
Bioorg Med Chem; 2004 May; 12(10):2571-87. PubMed ID: 15110839
[TBL] [Abstract][Full Text] [Related]
5. Thermodynamic criterion for the conformation of P1 residues of substrates and of inhibitors in complexes with serine proteinases.
Qasim MA; Lu SM; Ding J; Bateman KS; James MN; Anderson S; Song J; Markley JL; Ganz PJ; Saunders CW; Laskowski M
Biochemistry; 1999 Jun; 38(22):7142-50. PubMed ID: 10353824
[TBL] [Abstract][Full Text] [Related]
6. A novel serine protease inhibition motif involving a multi-centered short hydrogen bonding network at the active site.
Katz BA; Elrod K; Luong C; Rice MJ; Mackman RL; Sprengeler PA; Spencer J; Hataye J; Janc J; Link J; Litvak J; Rai R; Rice K; Sideris S; Verner E; Young W
J Mol Biol; 2001 Apr; 307(5):1451-86. PubMed ID: 11292354
[TBL] [Abstract][Full Text] [Related]
7. Crystal structure of the bovine alpha-chymotrypsin:Kunitz inhibitor complex. An example of multiple protein:protein recognition sites.
Capasso C; Rizzi M; Menegatti E; Ascenzi P; Bolognesi M
J Mol Recognit; 1997; 10(1):26-35. PubMed ID: 9179777
[TBL] [Abstract][Full Text] [Related]
8. Crystal structures of bovine chymotrypsin and trypsin complexed to the inhibitor domain of Alzheimer's amyloid beta-protein precursor (APPI) and basic pancreatic trypsin inhibitor (BPTI): engineering of inhibitors with altered specificities.
Scheidig AJ; Hynes TR; Pelletier LA; Wells JA; Kossiakoff AA
Protein Sci; 1997 Sep; 6(9):1806-24. PubMed ID: 9300481
[TBL] [Abstract][Full Text] [Related]
9. Structure-function relationship of serine protease-protein inhibitor interaction.
Otlewski J; Jaskólski M; Buczek O; Cierpicki T; Czapińska H; Krowarsch D; Smalas AO; Stachowiak D; Szpineta A; Dadlez M
Acta Biochim Pol; 2001; 48(2):419-28. PubMed ID: 11732612
[TBL] [Abstract][Full Text] [Related]
10. Kunitz-type soybean trypsin inhibitor revisited: refined structure of its complex with porcine trypsin reveals an insight into the interaction between a homologous inhibitor from Erythrina caffra and tissue-type plasminogen activator.
Song HK; Suh SW
J Mol Biol; 1998 Jan; 275(2):347-63. PubMed ID: 9466914
[TBL] [Abstract][Full Text] [Related]
11. Crystal structures of five bovine chymotrypsin complexes with P1 BPTI variants.
Czapinska H; Helland R; Smalås AO; Otlewski J
J Mol Biol; 2004 Dec; 344(4):1005-20. PubMed ID: 15544809
[TBL] [Abstract][Full Text] [Related]
12. Extended intermolecular interactions in a serine protease-canonical inhibitor complex account for strong and highly specific inhibition.
Fodor K; Harmat V; Hetényi C; Kardos J; Antal J; Perczel A; Patthy A; Katona G; Gráf L
J Mol Biol; 2005 Jul; 350(1):156-69. PubMed ID: 15922357
[TBL] [Abstract][Full Text] [Related]
13. Crystal structure of cancer chemopreventive Bowman-Birk inhibitor in ternary complex with bovine trypsin at 2.3 A resolution. Structural basis of Janus-faced serine protease inhibitor specificity.
Koepke J; Ermler U; Warkentin E; Wenzl G; Flecker P
J Mol Biol; 2000 May; 298(3):477-91. PubMed ID: 10772864
[TBL] [Abstract][Full Text] [Related]
14. Isolation, expression and characterization of a novel dual serine protease inhibitor, OH-TCI, from king cobra venom.
He YY; Liu SB; Lee WH; Qian JQ; Zhang Y
Peptides; 2008 Oct; 29(10):1692-9. PubMed ID: 18582511
[TBL] [Abstract][Full Text] [Related]
15. Structure of extracellular tissue factor complexed with factor VIIa inhibited with a BPTI mutant.
Zhang E; St Charles R; Tulinsky A
J Mol Biol; 1999 Feb; 285(5):2089-104. PubMed ID: 9925787
[TBL] [Abstract][Full Text] [Related]
16. Crystal structure of an elastase-specific inhibitor elafin complexed with porcine pancreatic elastase determined at 1.9 A resolution.
Tsunemi M; Matsuura Y; Sakakibara S; Katsube Y
Biochemistry; 1996 Sep; 35(36):11570-6. PubMed ID: 8794736
[TBL] [Abstract][Full Text] [Related]
17. The crystal structure of bikunin from the inter-alpha-inhibitor complex: a serine protease inhibitor with two Kunitz domains.
Xu Y; Carr PD; Guss JM; Ollis DL
J Mol Biol; 1998 Mar; 276(5):955-66. PubMed ID: 9566199
[TBL] [Abstract][Full Text] [Related]
18. Compromise and accommodation in ecotin, a dimeric macromolecular inhibitor of serine proteases.
Gillmor SA; Takeuchi T; Yang SQ; Craik CS; Fletterick RJ
J Mol Biol; 2000 Jun; 299(4):993-1003. PubMed ID: 10843853
[TBL] [Abstract][Full Text] [Related]
19. Binding of native and [homoserine lactone-52]-52,53-seco-bovine basic pancreatic trypsin inhibitor (Kunitz inhibitor) to porcine pancreatic beta-kallikrein-B and bovine alpha-chymotrypsin: thermodynamic study.
Oddone R; Barra D; Amiconi G; Ascenzi P; Tarricone C; Bolognesi M; Bortolotti F; Menegatti E
J Mol Recognit; 1994 Mar; 7(1):39-46. PubMed ID: 7527234
[TBL] [Abstract][Full Text] [Related]
20. Interscaffolding additivity: binding of P1 variants of bovine pancreatic trypsin inhibitor to four serine proteases.
Krowarsch D; Dadlez M; Buczek O; Krokoszynska I; Smalas AO; Otlewski J
J Mol Biol; 1999 May; 289(1):175-86. PubMed ID: 10339415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
